Ikezoe, Takayuki <br/><br/>
Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.  [electronic resource] 

 -  European journal of haematology  Nov 2013 
 - 442-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0609 
<br/><br/><label>Standard No.: </label>10.1111/ejh.12188  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticoagulants--therapeutic use<br/>Antithrombin III--therapeutic use<br/>Disseminated Intravascular Coagulation--drug therapy<br/>Female<br/>Hematologic Neoplasms--mortality<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Heparin--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--therapeutic use<br/>Solubility<br/>Survival Analysis<br/>Thrombomodulin--therapeutic use<br/>Treatment Outcome